Neurofilament Light as a biomarker for neurotoxicity after isolated limb perfusion - a prospective feasibility trial
SND-ID: 2023-251. Version: 1. DOI: https://doi.org/10.5878/ykq2-1r07
Associated documentation
Data PEK 4 all data codebook.docx (32.84 KB)
Data PEK 4 all data codebook.pdf (184.62 KB)
Data PEK 4 longitudinell codebook.docx (16.89 KB)
Data PEK 4 longitudinell codebook.pdf (56.76 KB)
PEK3 Alla analyser codebook.docx (109.04 KB)
PEK3 Alla analyser codebook.pdf (293.24 KB)
PEK3 longitudinella matningar codebook.docx (66.44 KB)
Citation
Creator/Principal investigator(s)
Anna Corderfeldt Keiller - University of Gothenburg, Institute of Clinical Sciences
Research principal
University of Gothenburg - Institute of Clinical Sciences, Department of Surgery
Description
Dataset contents:
Measurements, blood samples, health status.
Data contains personal data
Yes
Sensitive personal data
Yes
Type of personal data
Health status
Code key exists
Yes
Language
Unit of analysis
Population
Patients scheduled for isolated limb perfusion because of cancer tumours
Time Method
Study design
Experimental study
Description of study design
Explorative feasibility trial where patients scheduled for isolated limb perfusion were included. Blood samples were taken and a physiotherapist examined the patients pre- and post surgery for evaluation of nerve damage post isolated limb perfusion.
Sampling procedure
Time period(s) investigated
2019-04-12 – 2020-09-25
Biobank is connected to the study
The study has collected samples/material which are stored in a scientific collection or biobank
Scientific collection or biobank name: Biobank Sverige ID: PS-0499-5-001
Type(s) of sample: Blood samples
Variables
192
Number of individuals/objects
18
Research area
Physiology (Standard för svensk indelning av forskningsämnen 2011)
Cancer and oncology (Standard för svensk indelning av forskningsämnen 2011)
Specific diseases, disorders and medical conditions (CESSDA Topic Classification)
Corderfeldt Keiller A, Axelsson M, Bragadottir G, Blennow K, Zetterberg H, Olofsson Bagge R. A prospective feasibility trial exploring novel biomarkers for neurotoxicity after isolated limb perfusion. Perfusion. 2023;0(0). doi:10.1177/02676591231213506
DOI:
https://doi.org/10.1177/02676591231213506
If you have published anything based on these data, please notify us with a reference to your publication(s). If you are responsible for the catalogue entry, you can update the metadata/data description in DORIS.